Abstract
Background Despite the tremendous effort in basic, translational and clinical research, the standard-of-care of patients with glioblastoma (GBM) has been virtually unchanged for the past two decades, aside from tumor-treating...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have